Side-by-side financials for FULC and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FULC | NVS |
|---|---|---|
| Market cap | - | $293.12 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$74.88M | - |
| SEC filings | 477 | 947 |
Full pages: Fulcrum Therapeutics, Inc. and Novartis AG, or browse the full rankings.